Is Loblaw (TSX:L) stock a buy amid concerns of another COVID-19 wave?

3 min read | March 31, 2022 06:21 AM PDT | By Raza Naqvi

Highlights

  • At the end of the trading session on March 30, the Loblaw stock closed 0.1 per cent higher at C$ 111.16 per share.
  • Last year, Loblaw's e-commerce sales were C$ 3.1 billion, representing an annual increase of 13.9 per cent.
  • On March 14, 2022, Loblaw announced that its wholly-owned subsidiary Shoppers Drug Mart would acquire Lifemark Health Group.

Some public health experts have warned Canada that it is at a risk of a fresh COVID-19 wave. The warning comes as the authorities look to ease public health measures due to a significant drop in cases and a high vaccination rate.

In Ontario, free rapid antigen tests would be provided until the end of July as the Ontario Science Advisory Table reportedly anticipates a sixth wave of the coronavirus pandemic.

Some published reports suggest that Alexandra Hilkene, the press secretary from Minister of Health Christine Elliott, said that the tests would be available across pharmacies, grocery stores, hospitals, schools, and workplaces.

According to the Government of Canada, the country had 6,670 cases as of March 30. Meanwhile, the daily per cent positive was 15.7 per cent in the last seven days.

Also Read: American Lithium (LI) and Frontier (FL): 2 TSXV lithium stocks to buy

As concerns of another wave of the pandemic rise, let's find out if it is worth considering exploring consumer defensive retail stocks. In this article, we will be looking at the stock of Loblaw Companies Limited (TSX:L).

Loblaw Companies Limited (TSX:L): Key details

On March 14, 2022, Loblaw announced that its wholly-owned subsidiary Shoppers Drug Mart would acquire Lifemark Health Group for a cash consideration of C$ 845 million.

Lifemark is one of the leading providers of physiotherapy, chiropractic, mental health, and other ancillary rehabilitation services across 300 clinics.

The healthcare sector remains important as the pandemic continues and expanding the business by acquiring healthcare companies could help Loblaw grow in future.

On March 3, Loblaw's subsidiary T&T Supermarkets said it plans to open two new stores in Western Canada and two stores in Toronto and Montreal.

As the company's subsidiaries are looking to expand by opening new stores and acquiring companies, the parent company Loblaw Companies Limited, appears to be on the right track to continue expanding business operations.

At the end of the trading session on March 30, the Loblaw stock closed 0.1 per cent higher at C$ 111.16 per share. Notably, it is a dividend-paying stock, and Loblaw distributes a quarterly dividend of C$ 0.365 per unit, and its dividend yield was 1.3 per cent.

©2022 Kalkine Media® 

Bottom line

In Q4 2021, Loblaw's revenue was C$ 12,486 million, up 2.6 per cent year-over-year (YoY). Meanwhile, the operating income was C$ 705 million, representing an increase of C$ 70 million from Q4 2020.

Last year, Loblaw's e-commerce sales were C$ 3.1 billion, representing an annual increase of 13.9 per cent. Hence, if public health restrictions like a lockdown situation are enforced again, it seems that Loblaw is ready to face that situation.

Also Read: EMO, ODV, and DSV: 3 TSXV precious metals stocks to buy?

Please note, the above content constitutes a very preliminary observation or view based on digital trends and is of limited scope without any in-depth fundamental valuation or technical analysis. Any interest in stocks or sectors should be thoroughly evaluated taking into consideration the associated risks.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.